Quarterly Institutional Activity in KPRX

Shares Bought
Shares Sold
View Transactions

Top Institutions Holding KPRX

View all

Latest Institutional Activity in KPRX

Top Purchases

Q2 2022
Ubs Group Ag Shares Held: 28.9K ($97.8K)
Q2 2022
Geode Capital Management, LLC Shares Held: 547K ($1.85M)
Q2 2022
Captrust Financial Advisors Shares Held: 15K ($50.9K)
Q2 2022
Tower Research Capital LLC (Trc) Shares Held: 12.6K ($42.6K)
Q2 2022
Advisor Group Holdings, Inc. Shares Held: 1.47K ($4.98K)

Top Sells

Q3 2022
Vanguard Group Inc Shares Held: 0 ($0)
Q3 2022
Black Rock Inc. Shares Held: 0 ($0)
Q2 2022
Renaissance Technologies LLC Shares Held: 41.8K ($142K)
Q2 2022
Ergoteles LLC Shares Held: 0 ($0)
Q2 2022
Goldman Sachs Group Inc Shares Held: 0 ($0)

About KPRX

Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, develops and commercializes therapies for the treatment of ophthalmic diseases in the United States. Its lead product is KIO-301, a potential vision-restoring small molecule, which is in Phase 1 clinical trial that acts as a photoswitch to restore vision in patients with inherited and age-related degenerative retinal diseases. The company is also developing KIO-101, an eye drop that is in Phase 2 clinical trial for the treatment of ocular presentation of rheumatoid arthritis, as well as for treating non-infectious posterior uveitis; and KIO-201, an eye drop, which is in Phase 3 clinical trial for treating patients undergoing PRK surgery for corneal wound repair after refractive surgery. The company was formerly known as Eyegate Pharmaceuticals, Inc. and changed its name to Kiora Pharmaceuticals, Inc. in November 2021. Kiora Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Salt Lake City, Utah.


Insider Transactions at KPRX

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
52.9K Shares
From 11 Insiders
Open market or private purchase 22.3K shares
Grant, award, or other acquisition 30.6K shares
Sell / Disposition
0 Shares
From 0 Insiders

Track Institutional and Insider Activities on KPRX

Follow KIORA PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KPRX shares.

Notify only if

Insider Trading

Get notified when an Kiora Pharmaceuticals Inc insider buys or sells KPRX shares.

Notify only if

News

Receive news related to KIORA PHARMACEUTICALS INC

Track Activities on KPRX